Home-Based Respiratory Muscle Training and Aerobic Exercise Programs to Improve Lung Health in Current and Former Cigarette Smokers

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorRoswell Park Cancer Institute

About this trial

This clinical trial studies whether home-based respiratory muscle training (RMT) and aerobic exercise (AE) programs can be used to improve lung health in current and former cigarette smokers. Lung cancer, the leading cause of cancer death, is overwhelmingly caused by exposure to cigarette smoke. Research suggests that daily activity reduces lung cancer risk in current and former smokers. However, current and former smokers are generally not active and new approaches to improve lung health are needed. During the home-based RMT program, participants use a handheld device to complete breathing exercise sessions consisting of breathing in and out against adjustable resistance. During the home-based AE program, participants complete aerobic exercises using a stationary bike working at a moderate workload against adjustable resistance. The home-based RMT and AE programs may be effective ways to strengthen the breathing muscles, which may improve lung health in current and former cigarette smokers.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age ≥ 50 years old

Current smoker with a ≥ 20-pack-years history

Former smoker within the past 15 years, with a history of ≥ 20 pack-years (CT scan cohort only)

Participant must be able to speak, read and comprehend English language

Disqualifiers

Any previous lung cancer diagnoses and or undergoing treatment for any cancer

Recent pneumonia, bronchitis, or other inflammatory conditions in the lungs, including but limited to chronic obstructive pulmonary disease (COPD) and/or asthma exacerbation within the previous 6 months

Have uncontrolled intercurrent illness including, but not limited to, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, heart failure or psychiatric illness/social situations that would limit compliance with study requirements

Unwilling or unable to follow protocol requirements

Trial design

Design model

Parallel

Treatments tested in this trial

  • Accelerometry

    Procedure/Surgery

    Ancillary studies

  • Aerobic Exercise

    Other intervention

    Complete tailored intensity AE cycling sessions

  • Biospecimen Collection

    Procedure/Surgery

    Undergo blood, nasal swab, exhaled breath, and urine sample collection

  • Educational Intervention

    Other intervention

    Receive AE and RMT education

  • Electronic Health Record Review

    Other intervention

    Ancillary studies

  • Physical Performance Testing

    Other intervention

    Ancillary studies

  • Respiratory Muscle Training

    Procedure/Surgery

    Complete RMT sessions

  • Supportive Care

    Other intervention

    Receive virtually supervised session/call

  • Survey Administration

    Other intervention

    Ancillary studies

Treatment groups

200 Participants
are divided into 5 treatment groups
Group A: Cohort A Arm I (RMT)Experimental treatment 7 interventions
Group B: Cohort A Arm II (AE)Experimental treatment 7 interventions
Group C: Cohort A Arm III (AE and RMT education)Active comparator 6 interventions
Group D: Cohort B Arm IV (RMT)Experimental treatment 6 interventions
Group E: Cohort B Arm V (AE and RMT education)Active comparator 5 interventions

Trial outcomes

Primary outcomes

1

Compliance rate (Feasibility)

The primary objective is in the feasibility of conducting the respiratory muscle training (RMT) and aerobic exercise (AE) intervention relative to the sham control. In the RMT group, overall compliance (e.g., compliant at all time points) will be estimated using 90% confidence intervals (CIs) obtained Clopper-Pearson method. The lower bounds will define a plausible lower limit for true (unobserved) compliance rates. Additionally, compliance status will be modeled as a function of time (e.g., week), and pre-specified exogenous factors using a generalized estimating equation logistic regression model (autoregressive covariance structure). Estimates of compliance rates will be obtained by time-point and tests about the appropriate contrasts of model estimates will be used to determine if there is a time trend.

Time frame
Up to 12 weeks
2

Adherence rate (Feasibility)

The primary objective is in the feasibility of conducting the RMT and AE intervention relative to the sham control. In the RMT group, overall adherence (complete ≥ 70% of sessions) rates will be estimated using 90% CIs obtained Clopper-Pearson method. The lower bounds will define a plausible lower limit for true (unobserved) adherence rates.

Time frame
Up to 12 weeks
3

Assessing inspiratory and expiratory muscle strength

Participants will complete 3 sets of 15 breaths, 5 days/week using commercially available Power Lung. resistance will be increased 5-10% every week . Participants will rate and log their effort

Time frame
At baseline, 6 weeks, and 12 weeks
4

change in St. George Respiratory Questionnaire (SGRQ)

The SGRQ comprises of 50 items and consists of two parts. Scores range from 0-100, with higher scores indicating worse quality of life.

Time frame
At baseline, 6 weeks, and 12 weeks

Secondary outcomes

1

Lower extremity strength

Measured using the 30-Second Sit-to-Stand Test. The outcome will be analyzed using a linear mixed model, with the intervention arms and time points as predictors. Baseline measurements will be included as a covariate to adjust for initial differences. Both within-and between-group comparisons will be conducted using appropriate contrasts. The primary comparisons will focus on between-arm differences at the 12-week post-intervention time point.

Time frame
At baseline and 12 weeks
2

Physical performance

Measured using the Short Physical Performance Battery. The outcome will be analyzed using a linear mixed model, with the intervention arms and time points as predictors. Baseline measurements will be included as a covariate to adjust for initial differences. Both within-and between-group comparisons will be conducted using appropriate contrasts. The primary comparisons will focus on between-arm differences at the 12-week post-intervention time point.

Time frame
At baseline and 12 weeks
3

Physical activity levels

daily step counts and minutes at various intensity levels will be monitored with an activity tracker. Both within-and between-group comparisons will be conducted using appropriate contrasts. The primary comparisons will focus on between-arm differences at the 12-week post-intervention time point.

Time frame
Up to 12 weeks
4

Patient-reported outcomes on Fatigue

he Functional Assessment of Chronic Illness Therapy (FACIT- fatigue scale) is a 13-item patient-reported measure of fatigue. Items are scored on a 0 - 4 response scale with anchors ranging from "Not at all" to "Very much so". To score the FACIT-fatigue, all items are summed to create a single fatigue score with a range from 0 to 52. The higher the score, the lower the score the greater the fatigue severity

Time frame
At baseline and 12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: